Artículos por temáticas

Sleep, Orexin and Cognition

Toor B, Ray LB, Pozzobon A, Fogel SM.

Front Neurol Neurosci. 2021;45:38-51. doi: 10.1159/000514960. Epub 2021 May 28.

Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases

Pérez-Olives C, Rivas-Santisteban R, Lillo J, Navarro G, Franco R.

Adv Exp Med Biol. 2021;1264:81-92. doi: 10.1007/978-3-030-57369-0_6.

Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing

Reiten OK, Wilvang MA, Mitchell SJ, Hu Z, Fang EF.

Mech Ageing Dev. 2021 Oct;199:111567. doi: 10.1016/j.mad.2021.111567. Epub 2021 Sep 10.

The Conspicuous Link between Ear, Brain and Heart-Could Neurotrophin-Treatment of Age-Related Hearing Loss Help Prevent Alzheimer's Disease and Associated Amyloid Cardiomyopathy?

Shityakov S, Hayashi K, Störk S, Scheper V, Lenarz T, Förster CY.

Biomolecules. 2021 Jun 17;11(6):900. doi: 10.3390/biom11060900.

[Pharmacokinetics/Pharmacodynamic Analysis to Link Pharmacokinetics to Efficacy and Drug Interaction of Alzheimer's Disease Drugs]

Kiriyama A.

Yakugaku Zasshi. 2021;141(6):831-833. doi: 10.1248/yakushi.20-00251-3.

Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes

Radbakhsh S, Barreto GE, Bland AR, Sahebkar A.

Biofactors. 2021 Jul;47(4):570-586. doi: 10.1002/biof.1735. Epub 2021 Apr 24.

Alpiniae oxyphyllae Fructus and Alzheimer's disease: An update and current perspective on this traditional Chinese medicine

Li J, Du Q, Li N, Du S, Sun Z.

Biomed Pharmacother. 2021 Mar;135:111167. doi: 10.1016/j.biopha.2020.111167. Epub 2020 Dec 29.

Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD)

Oh ES, Rosenberg PB, Rattinger GB, Stuart EA, Lyketsos CG, Leoutsakos JS.

J Am Geriatr Soc. 2021 Apr;69(4):955-963. doi: 10.1111/jgs.16970. Epub 2020 Dec 31.

Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery

Hampel H, Vergallo A, Caraci F, Cuello AC, Lemercier P, Vellas B, Giudici KV, Baldacci F, Hänisch B, Haberkamp M, Broich K, Nisticò R, Emanuele E, Llavero F, Zugaza JL, Lucía A, Giacobini E, Lista S;

Neuropharmacology. 2021 Mar 1;185:108081. doi: 10.1016/j.neuropharm.2020.108081. Epub 2020 May 11.

Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)

Rombouts F, Kusakabe KI, Hsiao CC, Gijsen HJM.

Expert Opin Ther Pat. 2021 Jan;31(1):25-52. doi: 10.1080/13543776.2021.1832463. Epub 2020 Dec 17.

Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

Bautista-Aguilera ÓM, Ismaili L, Iriepa I, Diez-Iriepa D, Chabchoub F, Marco-Contelles J, Pérez M.

Chem Rec. 2021 Jan;21(1):162-174. doi: 10.1002/tcr.202000107. Epub 2020 Nov 10.

A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease

Mukhopadhyay S, Banerjee D.

J Alzheimers Dis. 2021;83(4):1537-1552. doi: 10.3233/JAD-215065.

Xanthone: Potential Acetylcholinesterase Inhibitor for Alzheimer's Disease Treatment

Vanessa VV, Mah SH.

Mini Rev Med Chem. 2021;21(17):2507-2529. doi: 10.2174/1389557521666210212152514.

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease

Lee JH, Kim HJ, Kim JU, Yook TH, Kim KH, Lee JY, Yang G.

Int J Mol Sci. 2021 Jan 28;22(3):1324. doi: 10.3390/ijms22031324.

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease

Rapaka D, Bitra VR, Challa SR, Adiukwu PC.

Neuropeptides. 2021 Dec;90:102196. doi: 10.1016/j.npep.2021.102196. Epub 2021 Sep 2.